[DOI] [PMC free article] [PubMed] [Google Scholar] 16.Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies (SURPASS programme) Kiyosue A, Dunn JP, Cui X, Hickey A, Hirase T, Imaoka T, Heine RJ
MDM Policy Pract
Gastrointestinal side effects such as nausea, diarrhea, or vomiting can reduce fluid and electrolyte levels, which, in turn, can provoke irregular heartbeats
However, severe vomiting, persistent diarrhea, signs of dehydration, or unexplained abdominal pain beyond week 6 warrant immediate communication with your prescribing clinician
This increases the risk of localized nodule formation (a palpable lump under the skin) that persists for days or weeks
Inflammatory markers in non-obese women with polycystic ovary syndrome are not elevated and show no correlation with vitamin d metabolites